Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9154841 | American Heart Journal | 2005 | 15 Pages |
Abstract
On August 24, 2004, an ad hoc group of experts representing clinical cardiovascular medicine, biostatistics, economics, and health policy were joined by representatives of the Food and Drug Administration, Centers for Medicare and Medicaid Services (Baltimore, Md), Agency for Healthcare Research and Quality (Rockville, Md), and the device industry for a 1-day round table to review the available clinical trial evidence on the effect of ICD therapy in the primary prevention of sudden cardiac death and the effect of CRT in patients with congestive heart failure. The meeting was organized by the Duke Clinical Research Institute, Durham, NC, and funded in part by the Agency for Healthcare Research and Quality. This document summarizes the evidence reviewed at that meeting and the discussions of that evidence.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sana M. MD, MHS, Gillian D. PhD, Daniel B. MD, MPH, Kerry L. PhD, Gust H. MD, J. Thomas MD, Alfred E. MD, Stuart MD, Alan MD, Arthur MD, Arthur M. MD, PhD, Kenneth A. MD, Steven MD, Robert M. MD,